CHAD LAHMAN: Open Payments
NPI 1235791757 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,180 in 21 payments from 10 companies in 2025. Trend: 2023 $15 · 2024 $156 · 2025 $1,180
Travel & lodging: $786Food & beverage: $394
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 5 | $857 |
| PFIZER INC. | 4 | $67 |
| E.R. Squibb & Sons, L.L.C. | 3 | $66 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $47 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| Novo Nordisk Inc | 1 | $25 |
| Haemonetics Corporation | 1 | $23 |
| AtriCure, Inc. | 1 | $20 |
| Amgen Inc. | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: LUX-Dx Insertable Cardiac Monitor, ELIQUIS, LifeVest, CAMZYOS, VERQUVO, CDS - MCT/CEM Monitoring, Wegovy, TEG6S HEMOSTASIS SYSTEM.
Industry payments across LA — which companies pay providers there.
